The finding that BMPs have a role in hematological malignancies is further strengthened as Grčević et al. [26] showed that expression of BMP4 and BMP6 was significantly higher in bone-marrow samples from multiple myeloma patients than from healthy controls. Here, CLN5 is linked to hematologic disorder.